mutation predictions | marginal predictions | summary statistics | genome diff | command line log
|
breseq version 0.33.1 revision 8505477f25b3
mutation predictions | marginal predictions | summary statistics | genome diff | command line log |
| Predicted mutations | ||||||
|---|---|---|---|---|---|---|
| evidence | position | mutation | freq | annotation | gene | description |
| RA | 9,710 | T→C | 6.1% | intergenic (+15/+72) | gyrA → / ← nnrD | DNA topoisomerase (ATP‑hydrolyzing) subunit A/possible carbohydrate kinase |
| RA | 9,716 | T→C | 7.4% | intergenic (+21/+66) | gyrA → / ← nnrD | DNA topoisomerase (ATP‑hydrolyzing) subunit A/possible carbohydrate kinase |
| RA | 9,719 | G→A | 6.5% | intergenic (+24/+63) | gyrA → / ← nnrD | DNA topoisomerase (ATP‑hydrolyzing) subunit A/possible carbohydrate kinase |
| RA | 29,365 | A→T | 5.7% | A182A (GCA→GCT) | yycI → | hypothetical protein YycI |
| RA | 35,814 | Δ1 bp | 20.2% | intergenic (+45/+63) | rlmH → / ← tpn | hypothetical protein/IS431mec transposase |
| RA | 35,817 | A→T | 21.0% | intergenic (+48/+60) | rlmH → / ← tpn | hypothetical protein/IS431mec transposase |
| RA | 35,850 | C→T | 28.1% | intergenic (+81/+27) | rlmH → / ← tpn | hypothetical protein/IS431mec transposase |
| RA | 35,858 | T→A | 32.8% | intergenic (+89/+19) | rlmH → / ← tpn | hypothetical protein/IS431mec transposase |
| RA | 35,876 | C→T | 38.2% | intergenic (+107/+1) | rlmH → / ← tpn | hypothetical protein/IS431mec transposase |
| RA | 35,913 | C→G | 21.0% | S213S (TCG→TCC) | tpn ← | IS431mec transposase |
| RA | 35,940 | G→A | 26.0% | R204R (CGC→CGT) | tpn ← | IS431mec transposase |
| RA | 35,970 | T→C | 54.6% | E194E (GAA→GAG) | tpn ← | IS431mec transposase |
| RA | 35,997 | T→C | 27.0% | T185T (ACA→ACG) | tpn ← | IS431mec transposase |
| RA | 36,015 | C→T | 27.8% | R179R (AGG→AGA) | tpn ← | IS431mec transposase |
| RA | 36,087 | A→G | 58.0% | C155C (TGT→TGC) | tpn ← | IS431mec transposase |
| RA | 36,119 | C→T | 30.2% | V145I (GTA→ATA) | tpn ← | IS431mec transposase |
| RA | 36,124 | G→A | 58.0% | A143V (GCT→GTT) | tpn ← | IS431mec transposase |
| RA | 36,133 | A→G | 26.7% | V140A (GTA→GCA) | tpn ← | IS431mec transposase |
| RA | 36,161 | T→C | 29.0% | I131V (ATT→GTT) | tpn ← | IS431mec transposase |
| RA | 36,174 | T→C | 29.2% | K126K (AAA→AAG) | tpn ← | IS431mec transposase |
| RA | 36,269 | C→T | 51.9% | A95T (GCA→ACA) | tpn ← | IS431mec transposase |
| RA | 36,315 | G→A | 51.4% | Y79Y (TAC→TAT) | tpn ← | IS431mec transposase |
| RA | 36,378 | C→T | 77.8% | L58L (TTG→TTA) | tpn ← | IS431mec transposase |
| RA | 36,413 | C→T | 45.9% | V47I (GTC→ATC) | tpn ← | IS431mec transposase |
| RA | 36,444 | C→T | 35.1% | R36R (AGG→AGA) | tpn ← | IS431mec transposase |
| RA | 36,471 | A→G | 16.3% | S27S (AGT→AGC) | tpn ← | IS431mec transposase |
| RA | 36,479 | T→C | 14.4% | T25A (ACA→GCA) | tpn ← | IS431mec transposase |
| RA | 36,581 | C→T | 23.9% | intergenic (‑30/‑493) | tpn ← / → USA300HOU_0028 | IS431mec transposase/hypothetical protein |
| RA | 76,180 | C→T | 20.5% | intergenic (+238/‑896) | USA300HOU_0072 → / → USA300HOU_0075 | universal stress protein/lysophospholipase |
| RA | 76,185 | G→A | 9.9% | intergenic (+243/‑891) | USA300HOU_0072 → / → USA300HOU_0075 | universal stress protein/lysophospholipase |
| RA | 76,265 | C→T | 36.4% | intergenic (+323/‑811) | USA300HOU_0072 → / → USA300HOU_0075 | universal stress protein/lysophospholipase |
| RA | 76,295 | T→C | 49.0% | intergenic (+353/‑781) | USA300HOU_0072 → / → USA300HOU_0075 | universal stress protein/lysophospholipase |
| RA | 76,322 | G→A | 46.2% | intergenic (+380/‑754) | USA300HOU_0072 → / → USA300HOU_0075 | universal stress protein/lysophospholipase |
| RA | 76,353 | G→A | 44.2% | intergenic (+411/‑723) | USA300HOU_0072 → / → USA300HOU_0075 | universal stress protein/lysophospholipase |
| RA | 79,612 | A→T | 5.7% | intergenic (+221/‑39) | USA300HOU_0076 → / → USA300HOU_0077 | transposase/possible S‑adenosyl‑L‑methionine‑dependent methyltransferase |
| RA | 92,987 | A→G | 7.7% | intergenic (‑72/‑65) | yrkD ← / → yrkE | hypothetical protein/hypothetical protein |
| RA | 110,651 | C→T | 17.9% | D170D (GAC→GAT) | USA300HOU_0109 → | staphylococcal tandem lipoprotein |
| RA | 110,660 | T→A | 30.1% | I173I (ATT→ATA) | USA300HOU_0109 → | staphylococcal tandem lipoprotein |
| RA | 111,041 | C→T | 5.2% | G37G (GGC→GGT) | USA300HOU_0110 → | possible staphylococcal tandem lipoprotein |
| RA | 111,512 | A→G | 34.0% | S194S (TCA→TCG) | USA300HOU_0110 → | possible staphylococcal tandem lipoprotein |
| RA | 111,516 | C→A | 31.8% | Q196K (CAA→AAA) | USA300HOU_0110 → | possible staphylococcal tandem lipoprotein |
| RA | 111,560 | T→C | 9.9% | R210R (CGT→CGC) | USA300HOU_0110 → | possible staphylococcal tandem lipoprotein |
| RA | 217,036 | T→A | 9.9% | intergenic (‑203/+23) | argD ← / ← brnQ | ornithine‑‑oxo‑acid transaminase/possible LIVCS family branched chain amino acid:cation symporter |
| RA | 250,730 | A→G | 7.3% | V37V (GTA→GTG) | USA300HOU_0224 → | possible dehydrogenase |
| RA | 290,156 | A→T | 5.5% | intergenic (+47/‑180) | USA300HOU_0257 → / → gatC1 | PTS family galactitol (gat) porter component IIB/PTS family galactitol (gat) porter component IIC |
| RA | 307,836 | A→G | 7.3% | E28E (GAA→GAG) | lytR → | response regulator LytR |
| RA | 427,535 | G→A | 6.4% | Q52* (CAA→TAA) | USA300HOU_0402 ← | hypothetical protein |
| RA | 512,643 | A→G | 54.2% | intergenic (+711/‑150) | recR → / → rrs1 | recombination protein RecR/16S ribosomal RNA |
| RA | 568,992 | A→T | 6.8% | E285V (GAA→GTA) | mcsB → | possible phosphotransferase |
| RA | 598,486 | T→C | 7.5% | intergenic (+35/+247) | tufA → / ← yhaA | elongation factor EF1A/M20D subfamily peptidase |
| RA | 623,744 | A→G | 8.8% | I242V (ATT→GTT) | USA300HOU_0558 → | glycosyltransferase |
| RA | 623,752 | A→G | 8.2% | V244V (GTA→GTG) | USA300HOU_0558 → | glycosyltransferase |
| RA | 623,777 | G→A | 7.0% | A253T (GCC→ACC) | USA300HOU_0558 → | glycosyltransferase |
| RA | 745,839 | G→C | 9.3% | A46P (GCT→CCT) | yeeN → | hypothetical protein |
| RA | 792,484 | A→T | 7.0% | N504Y (AAC→TAC) | ltaS → | possible phosphatidylglycerol‑‑membrane‑oligosaccharide glycerophosphotransferase |
| RA | 802,515 | A→T | 7.7% | P262P (CCT→CCA) | dgkA1 ← | possible diacylglycerol kinase |
| RA | 846,387 | A→T | 5.4% | S278S (TCA→TCT) | yvcD → | hypothetical TPR domain protein |
| RA | 937,158 | T→A | 10.2% | intergenic (+65/‑1952) | yumB → / → USA300HOU_0903 | NADH dehydrogenase/NhaC family sodium:proton (Na+:H+) antiporter |
| RA | 988,184 | T→C | 8.5% | M30T (ATG→ACG) | oppB1 → | oligopeptide ABC superfamily ATP binding cassette transporter, membrane protein |
| RA | 1,002,200 | T→G | 7.6% | M173R (ATG→AGG) | mecA2 → | competence negative regulator MecA |
| RA | 1,073,800 | C→A | 10.5% | S136Y (TCT→TAT) | purE → | 5‑(carboxyamino)imidazole ribonucleotide mutase |
| RA | 1,178,095 | C→G | 5.9% | S148C (TCT→TGT) | arcD2 → | arginine/ornithine APC family amino acid‑polyamine‑organocation transporter, antiporter |
| RA | 1,246,388 | A→G | 6.4% | H201R (CAT→CGT) | rnc → | ribonuclease III |
| RA | 1,289,745 | C→T | 5.3% | P7L (CCG→CTG) | ylxR → | hypothetical protein |
| RA | 1,305,233 | T→C | 7.1% | F194F (TTT→TTC) | ymfH → | M16C subfamily peptidase |
| RA | 1,396,841 | A→T | 6.5% | I481F (ATT→TTT) | fmtC → | lysyl transferase |
| RA | 1,416,458 | A→T | 100% | I216N (ATT→AAT) | oppD ← | oligopeptide ABC superfamily ATP binding cassette transporter, ABC protein |
| RA | 1,513,930 | A→T | 100% | L413F (TTA→TTT) | USA300HOU_1379 → | hypothetical membrane protein |
| RA | 1,514,408 | T→C | 7.0% | K55E (AAA→GAA) | USA300HOU_1380 ← | hypothetical protein |
| RA | 1,546,648 | A→G | 7.1% | F149F (TTT→TTC) | rpsA ← | ribosomal protein S1 |
| RA | 1,575,517 | G→A | 6.8% | A667V (GCA→GTA) | hlgB ← | possible bacteriophage tail protein |
| RA | 1,621,188 | A→G | 8.4% | Y85C (TAT→TGT) | zwf → | glucose‑6‑phosphate 1‑dehydrogenase |
| RA | 1,646,189 | G→C | 100% | A155G (GCA→GGA) | pepP ← | M24B family Xaa‑Pro dipeptidase |
| RA | 1,653,327 | A→G | 5.7% | intergenic (‑32/+127) | gcvT ← / ← aroK | aminomethyltransferase/shikimate kinase |
| RA | 1,714,061 | A→G | 5.6% | C243R (TGT→CGT) | accC ← | biotin carboxylase |
| RA | 1,716,360 | C→A | 9.2% | W209C (TGG→TGT) | kipI ← | possible allophanate hydrolase subunit 1 |
| RA | 1,755,685 | Δ1 bp | 8.0% | intergenic (‑82/+273) | obg ← / ← rpmA | GTP‑binding protein/ribosomal protein L27 |
| RA | 1,779,807 | A→G | 7.8% | intergenic (‑1832/+1417) | tig ← / ← lysP | peptidylprolyl isomerase/APC family amino acid‑polyamine‑organocation transporter |
| RA | 1,779,810 | A→T | 8.2% | intergenic (‑1835/+1414) | tig ← / ← lysP | peptidylprolyl isomerase/APC family amino acid‑polyamine‑organocation transporter |
| RA | 1,779,813 | C→T | 8.2% | intergenic (‑1838/+1411) | tig ← / ← lysP | peptidylprolyl isomerase/APC family amino acid‑polyamine‑organocation transporter |
| RA | 1,894,054 | A→G | 6.9% | L87S (TTA→TCA) | USA300HOU_1755 ← | lysophospholipase |
| RA | 1,913,866 | T→C | 6.7% | Y213C (TAT→TGT) | ytbE ← | hypothetical protein |
| RA | 1,920,410 | C→A | 5.7% | V306L (GTG→TTG) | menC ← | possible o‑succinylbenzoic acid (OSB) synthetase |
| RA | 1,929,796 | T→C | 19.7% | intergenic (‑879/‑289) | USA300HOU_1794 ← / → USA300HOU_1796 | hypothetical protein/hypothetical protein |
| RA | 1,929,797 | G→A | 19.5% | intergenic (‑880/‑288) | USA300HOU_1794 ← / → USA300HOU_1796 | hypothetical protein/hypothetical protein |
| RA | 1,929,799 | C→A | 20.4% | intergenic (‑882/‑286) | USA300HOU_1794 ← / → USA300HOU_1796 | hypothetical protein/hypothetical protein |
| RA | 1,929,804 | A→G | 22.4% | intergenic (‑887/‑281) | USA300HOU_1794 ← / → USA300HOU_1796 | hypothetical protein/hypothetical protein |
| RA | 1,929,812 | G→A | 28.8% | intergenic (‑895/‑273) | USA300HOU_1794 ← / → USA300HOU_1796 | hypothetical protein/hypothetical protein |
| RA | 1,929,843 | Δ1 bp | 40.3% | intergenic (‑926/‑242) | USA300HOU_1794 ← / → USA300HOU_1796 | hypothetical protein/hypothetical protein |
| RA | 1,929,848 | C→A | 41.8% | intergenic (‑931/‑237) | USA300HOU_1794 ← / → USA300HOU_1796 | hypothetical protein/hypothetical protein |
| RA | 1,929,861 | T→C | 42.4% | intergenic (‑944/‑224) | USA300HOU_1794 ← / → USA300HOU_1796 | hypothetical protein/hypothetical protein |
| RA | 1,929,862:1 | +T | 37.0% | intergenic (‑945/‑223) | USA300HOU_1794 ← / → USA300HOU_1796 | hypothetical protein/hypothetical protein |
| RA | 1,929,865 | A→C | 37.5% | intergenic (‑948/‑220) | USA300HOU_1794 ← / → USA300HOU_1796 | hypothetical protein/hypothetical protein |
| RA | 1,929,866 | G→T | 42.3% | intergenic (‑949/‑219) | USA300HOU_1794 ← / → USA300HOU_1796 | hypothetical protein/hypothetical protein |
| RA | 1,929,867 | G→T | 41.4% | intergenic (‑950/‑218) | USA300HOU_1794 ← / → USA300HOU_1796 | hypothetical protein/hypothetical protein |
| RA | 1,929,870 | A→C | 42.1% | intergenic (‑953/‑215) | USA300HOU_1794 ← / → USA300HOU_1796 | hypothetical protein/hypothetical protein |
| RA | 1,929,872 | G→A | 41.3% | intergenic (‑955/‑213) | USA300HOU_1794 ← / → USA300HOU_1796 | hypothetical protein/hypothetical protein |
| RA | 1,929,873 | C→A | 41.9% | intergenic (‑956/‑212) | USA300HOU_1794 ← / → USA300HOU_1796 | hypothetical protein/hypothetical protein |
| RA | 1,929,875 | T→C | 41.9% | intergenic (‑958/‑210) | USA300HOU_1794 ← / → USA300HOU_1796 | hypothetical protein/hypothetical protein |
| RA | 1,929,917 | C→T | 29.4% | intergenic (‑1000/‑168) | USA300HOU_1794 ← / → USA300HOU_1796 | hypothetical protein/hypothetical protein |
| RA | 1,929,918 | A→G | 29.9% | intergenic (‑1001/‑167) | USA300HOU_1794 ← / → USA300HOU_1796 | hypothetical protein/hypothetical protein |
| RA | 1,929,925 | T→A | 25.9% | intergenic (‑1008/‑160) | USA300HOU_1794 ← / → USA300HOU_1796 | hypothetical protein/hypothetical protein |
| RA | 1,929,928 | T→A | 26.2% | intergenic (‑1011/‑157) | USA300HOU_1794 ← / → USA300HOU_1796 | hypothetical protein/hypothetical protein |
| RA | 1,929,930 | T→A | 26.2% | intergenic (‑1013/‑155) | USA300HOU_1794 ← / → USA300HOU_1796 | hypothetical protein/hypothetical protein |
| RA | 1,929,941 | A→T | 21.9% | intergenic (‑1024/‑144) | USA300HOU_1794 ← / → USA300HOU_1796 | hypothetical protein/hypothetical protein |
| RA | 1,929,946 | G→A | 17.9% | intergenic (‑1029/‑139) | USA300HOU_1794 ← / → USA300HOU_1796 | hypothetical protein/hypothetical protein |
| RA | 1,944,006 | A→G | 10.8% | F138F (TTT→TTC) | splA ← | S1B family serine protease SplA |
| RA | 2,010,363 | C→T | 100% | C146Y (TGT→TAT) | ygaD ← | ABC superfamily ATP binding cassette transporter, membrane protein |
| RA | 2,040,533 | T→C | 6.6% | N129D (AAT→GAT) | dagK ← | hypothetical protein |
| RA | 2,153,598 | A→G | 5.7% | Y216H (TAT→CAT) | scrR ← | sucrose operon repressor |
| RA | 2,212,513 | A→G | 7.0% | I21I (ATT→ATC) | yidC ← | hypothetical membrane protein |
| RA | 2,268,572 | A→T | 12.3% | intergenic (‑460/+78) | USA300HOU_2142 ← / ← USA300HOU_2143 | hypothetical protein/possible HAD superfamily hydrolase |
| RA | 2,279,705 | G→A | 100% | intergenic (+1373/+6659) | mtlD → / ← glmM | mannitol‑1‑phosphate 5‑dehydrogenase/phosphoglucosamine mutase |
| RA | 2,286,977 | A→G | 6.0% | I248T (ATC→ACC) | glmM ← | phosphoglucosamine mutase |
| RA | 2,372,413 | C→G | 9.8% | intergenic (‑5530/+28) | rpmC ← / ← pbuG | ribosomal protein L29/NCS2 family nucleobase:cation symporter‑2 |
| RA | 2,448,484 | A→G | 9.1% | intergenic (‑243/+34) | hipO ← / ← hutI | M20D subfamily peptidase/imidazolonepropionase |
| RA | 2,448,493 | C→T | 10.4% | intergenic (‑252/+25) | hipO ← / ← hutI | M20D subfamily peptidase/imidazolonepropionase |
| RA | 2,448,498 | C→T | 8.3% | intergenic (‑257/+20) | hipO ← / ← hutI | M20D subfamily peptidase/imidazolonepropionase |
| RA | 2,530,791 | C→T | 9.8% | intergenic (‑42/+123) | USA300HOU_2388 ← / ← USA300HOU_2389 | hypothetical protein/hypothetical protein |
| RA | 2,532,298 | A→T | 100% | T15T (ACA→ACT) | murN → | FemAB family peptidoglycan biosynthesis protein |
| RA | 2,608,825 | A→T | 8.6% | intergenic (‑676/+154) | USA300HOU_2470 ← / ← USA300HOU_2471 | dehydrogenase/hypothetical protein |
| RA | 2,608,829 | C→T | 8.5% | intergenic (‑680/+150) | USA300HOU_2470 ← / ← USA300HOU_2471 | dehydrogenase/hypothetical protein |
| RA | 2,614,139 | A→T | 6.1% | S178T (TCA→ACA) | USA300HOU_2478 ← | lipoprotein |
| RA | 2,620,970 | A→G | 7.3% | K42E (AAA→GAA) | USA300HOU_2484 → | hypothetical membrane protein |
| RA | 2,636,962 | A→T | 6.6% | Y271* (TAT→TAA) | gntP ← | GntP family gluconate:proton (H+) symporter |
| RA | 2,636,965 | A→T | 7.5% | I270I (ATT→ATA) | gntP ← | GntP family gluconate:proton (H+) symporter |
| RA | 2,669,453 | C→T | 7.3% | A118V (GCT→GTT) | yicL → | DMT superfamily drug/metabolite transporter |
| RA | 2,669,457 | G→A | 6.5% | A119A (GCG→GCA) | yicL → | DMT superfamily drug/metabolite transporter |
| RA | 2,669,460 | T→C | 6.4% | I120I (ATT→ATC) | yicL → | DMT superfamily drug/metabolite transporter |
| RA | 2,669,464 | A→G | 6.3% | T122A (ACA→GCA) | yicL → | DMT superfamily drug/metabolite transporter |
| RA | 2,680,121 | C→T | 13.9% | intergenic (+173/+359) | cbpD → / ← USA300HOU_2537 | possible secretory antigen/hypothetical protein |
| RA | 2,680,123 | A→T | 17.2% | intergenic (+175/+357) | cbpD → / ← USA300HOU_2537 | possible secretory antigen/hypothetical protein |
| RA | 2,680,126 | A→G | 17.2% | intergenic (+178/+354) | cbpD → / ← USA300HOU_2537 | possible secretory antigen/hypothetical protein |
| RA | 2,680,132 | A→G | 17.1% | intergenic (+184/+348) | cbpD → / ← USA300HOU_2537 | possible secretory antigen/hypothetical protein |
| RA | 2,680,133 | T→C | 17.0% | intergenic (+185/+347) | cbpD → / ← USA300HOU_2537 | possible secretory antigen/hypothetical protein |
| RA | 2,680,137 | T→C | 16.5% | intergenic (+189/+343) | cbpD → / ← USA300HOU_2537 | possible secretory antigen/hypothetical protein |
| RA | 2,680,139 | G→A | 16.3% | intergenic (+191/+341) | cbpD → / ← USA300HOU_2537 | possible secretory antigen/hypothetical protein |
| RA | 2,680,141 | T→C | 17.0% | intergenic (+193/+339) | cbpD → / ← USA300HOU_2537 | possible secretory antigen/hypothetical protein |
| RA | 2,680,166 | T→C | 10.9% | intergenic (+218/+314) | cbpD → / ← USA300HOU_2537 | possible secretory antigen/hypothetical protein |
| RA | 2,696,558 | T→C | 5.9% | intergenic (+110/‑130) | USA300HOU_2551 → / → copA | hypothetical protein/P‑ATPase superfamily P‑type ATPase copper (Cu2+) transporter |
| RA | 2,696,559 | T→C | 6.0% | intergenic (+111/‑129) | USA300HOU_2551 → / → copA | hypothetical protein/P‑ATPase superfamily P‑type ATPase copper (Cu2+) transporter |
| RA | 2,745,325 | T→A | 6.3% | N143I (AAT→ATT) | mqo2 ← | malate dehydrogenase (acceptor) |
| RA | 2,769,004 | A→G | 7.2% | V35A (GTT→GCT) | gpo ← | ABC superfamily ATP binding cassette transporter, ABC protein |
| RA | 2,787,555 | G→A | 5.2% | intergenic (+101/‑139) | USA300HOU_2639 → / → USA300HOU_2640 | hypothetical protein/BglG family transcriptional antiterminator |
| RA | 2,811,059 | T→C | 6.5% | I109V (ATT→GTT) | secY2 ← | Sec family Type I general secretory pathway protein SecY |
| RA | 2,863,480 | G→T | 9.3% | L36L (CTC→CTA) | USA300HOU_2707 ← | hypothetical protein |
| Unassigned new junction evidence | |||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|
| seq id | position | reads (cov) | reads (cov) | score | skew | freq | annotation | gene | product | ||
| * | ? | CP000730 | 512620 = | 56 (1.020) | 41 (1.090) +40 bp |
35/174 | NT | 51.7% | intergenic (+688/‑173) | recR/rrs1 | recombination protein RecR/16S ribosomal RNA |
| ? | CP000730 | 1998278 = | NA (NA) | intergenic (‑6/+5) | USA300HOU_t0050/rrf4 | tRNA‑Val/5S ribosomal RNA | |||||
| * | ? | CP000730 | 531230 = | 49 (0.890) | 4 (0.080) | 4/242 | NT | 8.5% | intergenic (+801/‑4924) | veg/rplY | hypothetical protein/ribosomal protein L25 |
| ? | CP000730 | 531269 = | 39 (0.740) | intergenic (+840/‑4885) | veg/rplY | hypothetical protein/ribosomal protein L25 | |||||
| * | ? | CP000730 | = 547170 | 33 (0.600) | 4 (0.080) | 4/238 | NT | 11.6% | intergenic (+70/‑187) | hpt/ftsH | hypoxanthine phosphoribosyltransferase/cell division protein FtsH |
| ? | CP000730 | = 547176 | 30 (0.580) | intergenic (+76/‑181) | hpt/ftsH | hypoxanthine phosphoribosyltransferase/cell division protein FtsH | |||||
| * | ? | CP000730 | = 553221 | 38 (0.690) | 5 (0.100) | 4/232 | NT | 12.7% | intergenic (+188/‑2871) | folB/rrf2 | dihydroneopterin aldolase/5S ribosomal RNA |
| ? | CP000730 | = 553245 | 34 (0.680) | intergenic (+212/‑2847) | folB/rrf2 | dihydroneopterin aldolase/5S ribosomal RNA | |||||
| * | ? | CP000730 | = 895725 | 55 (1.000) | 3 (0.060) | 3/240 | NT | 5.2% | coding (746/822 nt) | metQ | ABC superfamily ATP binding cassette transporter, binding protein |
| ? | CP000730 | = 895759 | 57 (1.100) | coding (780/822 nt) | metQ | ABC superfamily ATP binding cassette transporter, binding protein | |||||
| * | ? | CP000730 | = 1066493 | 35 (0.640) | 3 (0.060) | 3/238 | NT | 7.6% | intergenic (+361/+176) | fmt1/qoxD | S12 family carboxypeptidase/possible cytochrome c oxidase subunit IV |
| ? | CP000730 | = 1066509 | 40 (0.780) | intergenic (+377/+160) | fmt1/qoxD | S12 family carboxypeptidase/possible cytochrome c oxidase subunit IV | |||||
| * | ? | CP000730 | = 1555341 | 51 (0.930) | 3 (0.060) | 3/234 | NT | 6.1% | intergenic (+37/+69) | fer/ribU | ferredoxin/hypothetical membrane protein |
| ? | CP000730 | = 1555365 | 45 (0.890) | intergenic (+61/+45) | fer/ribU | ferredoxin/hypothetical membrane protein | |||||
| * | ? | CP000730 | 1805304 = | 43 (0.780) | 4 (0.080) | 4/238 | NT | 9.2% | intergenic (+2276/+49) | cycA/pykA | APC family amino acid‑polyamine‑organocation transporter/pyruvate kinase |
| ? | CP000730 | 1805347 = | 39 (0.760) | intergenic (+2319/+6) | cycA/pykA | APC family amino acid‑polyamine‑organocation transporter/pyruvate kinase | |||||
| * | ? | CP000730 | 2141638 = | 51 (0.930) | 3 (0.060) | 3/242 | NT | 5.9% | coding (450/1617 nt) | groEL | chaperone GroEL |
| ? | CP000730 | 2141666 = | 47 (0.900) | coding (422/1617 nt) | groEL | chaperone GroEL | |||||
| * | ? | CP000730 | = 2440052 | 46 (0.840) | 5 (0.100) | 5/230 | NT | 10.5% | intergenic (+13/+53) | USA300HOU_2302/glvC | hypothetical protein/PTS family arbutin‑salicin‑cellobiose (ASC) porter component IIBC |
| ? | CP000730 | = 2440086 | 44 (0.880) | intergenic (+47/+19) | USA300HOU_2302/glvC | hypothetical protein/PTS family arbutin‑salicin‑cellobiose (ASC) porter component IIBC | |||||
| * | ? | CP000730 | 2609395 = | 51 (0.930) | 5 (0.100) | 5/230 | NT | 10.6% | intergenic (‑225/‑210) | USA300HOU_2471/USA300HOU_2472 | hypothetical protein/hypothetical protein |
| ? | CP000730 | 2609451 = | 38 (0.760) | intergenic (‑281/‑154) | USA300HOU_2471/USA300HOU_2472 | hypothetical protein/hypothetical protein | |||||
| * | ? | CP000730 | = 2716752 | 42 (0.760) | 3 (0.060) | 3/232 | NT | 6.2% | intergenic (+60/+90) | ynzC/USA300HOU_2569 | hypothetical protein/possible lactoylglutatione lyase |
| ? | CP000730 | = 2716804 | 53 (1.050) | intergenic (+112/+38) | ynzC/USA300HOU_2569 | hypothetical protein/possible lactoylglutatione lyase | |||||
| * | ? | CP000730 | = 2830200 | 63 (1.150) | 5 (0.100) | 5/232 | NT | 8.4% | intergenic (+28/+163) | icaC/USA300HOU_2670 | intercellular adhesion protein C/hypothetical protein |
| ? | CP000730 | = 2830235 | 51 (1.010) | intergenic (+63/+128) | icaC/USA300HOU_2670 | intercellular adhesion protein C/hypothetical protein | |||||
| * | ? | CP000730 | 2850817 = | 70 (1.270) | 4 (0.080) | 4/226 | NT | 6.3% | intergenic (+16/+103) | pcp/USA300HOU_2693 | C15 family pyroglutamyl‑peptidase I/hypothetical protein |
| ? | CP000730 | 2850866 = | 57 (1.160) | intergenic (+65/+54) | pcp/USA300HOU_2693 | C15 family pyroglutamyl‑peptidase I/hypothetical protein | |||||